Scholarlink

<p>Leiomyosarcomas are malignant smooth muscle tumors that rarely originate in the retroperitoneum and are extremely uncommon in relation to the infundibulopelvic ligament (ovarian pedicle). We report the case of a 68 year old female who presented with right lower abdominal pain radiating to the back. Imaging revealed a retroperitoneal mass abutting vital structures with preserved fat planes. Core biopsy suggested leiomyosarcoma, and the patient underwent complete surgical excision with right ureteric stenting and lymphadenectomy. Histopathology confirmed a conventional leiomyosarcoma (FNCLCC grade 2, pT2N0). Given the complete R0 resection, intermediate grade and absence of metastases, adjuvant therapy was withheld, and the patient remains disease free at 2 years of follow up. This report highlights the clinical, radiologic, pathologic, and therapeutic considerations of this exceedingly rare tumor, with an emphasis on diagnostic differentiation and management strategies supported by current literature.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Primary Leiomyosarcoma Arising from the Right Infundibulopelvic Ligament (Ovarian Pedicle): A Rare Retroperitoneal Tumor

  • 期刊论文

  • 发表日期：

    2026年1月7日

查看全文
  • Rajshekhar C Jaka,
  • Aishwarya Madasamy Swaminathan,
  • Nayana N S

摘要

Leiomyosarcomas are malignant smooth muscle tumors that rarely originate in the retroperitoneum and are extremely uncommon in relation to the infundibulopelvic ligament (ovarian pedicle). We report the case of a 68 year old female who presented with right lower abdominal pain radiating to the back. Imaging revealed a retroperitoneal mass abutting vital structures with preserved fat planes. Core biopsy suggested leiomyosarcoma, and the patient underwent complete surgical excision with right ureteric stenting and lymphadenectomy. Histopathology confirmed a conventional leiomyosarcoma (FNCLCC grade 2, pT2N0). Given the complete R0 resection, intermediate grade and absence of metastases, adjuvant therapy was withheld, and the patient remains disease free at 2 years of follow up. This report highlights the clinical, radiologic, pathologic, and therapeutic considerations of this exceedingly rare tumor, with an emphasis on diagnostic differentiation and management strategies supported by current literature.